Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.42 USD | -4.60% | +16.30% | +166.25% |
12:40pm | HC Wainwright Initiates Dianthus Therapeutics With Buy Rating, $40 Price Target | MT |
May. 10 | Wedbush Adjusts Dianthus Therapeutics' Price Target to $38 From $33, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+166.25% | 813M | |
+8.07% | 113B | |
+10.46% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-4.82% | 17.24B | |
+6.66% | 14.29B | |
+36.07% | 12.52B |
- Stock Market
- Equities
- DNTH Stock
- News Dianthus Therapeutics, Inc.
- Jefferies Initiates Dianthus Therapeutics at Buy With $22 Price Target